STOCK TITAN

Callan JMB Unveils Innovative Immunization Management Infrastructure Lease Program for Government Agencies and Private Organizations

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

Callan JMB (NASDAQ: CJMB) has launched an innovative lease program for immunization management infrastructure, targeting government agencies and private organizations. The program offers comprehensive vaccine management solutions without requiring substantial upfront equipment investments.

The lease package includes refrigerators, freezers, ultra-cold units, generators, computer equipment, and mobile clinic kits, all monitored by their proprietary Sentry system. This solution helps organizations avoid investing approximately $100,000 in equipment purchases.

The company's track record includes managing 2.27 million COVID-19 vaccine doses, 32.2 million testing supplies, and 113,401 COVID-19 therapeutics for Texas Department of State Health Services from April 2020 through January 2024. Callan JMB operates vaccine management centers in Texas, Oregon, and Illinois.

Callan JMB (NASDAQ: CJMB) ha lanciato un programma di leasing innovativo per la gestione delle infrastrutture di immunizzazione, rivolto a enti governativi e organizzazioni private. Il programma offre soluzioni complete per la gestione dei vaccini senza richiedere ingenti investimenti iniziali in attrezzature.

Il pacchetto di leasing include frigoriferi, congelatori, unità a temperatura ultra-bassa, generatori, attrezzature informatiche e kit per cliniche mobili, tutti monitorati dal loro sistema proprietario Sentry. Questa soluzione aiuta le organizzazioni ad evitare di investire circa $100,000 nell'acquisto di attrezzature.

Il track record dell'azienda include la gestione di 2,27 milioni di dosi di vaccino COVID-19, 32,2 milioni di forniture per test e 113.401 terapie COVID-19 per il Dipartimento dei Servizi Sanitari dello Stato del Texas da aprile 2020 a gennaio 2024. Callan JMB gestisce centri di gestione dei vaccini in Texas, Oregon e Illinois.

Callan JMB (NASDAQ: CJMB) ha lanzado un programa de arrendamiento innovador para la infraestructura de gestión de inmunización, dirigido a agencias gubernamentales y organizaciones privadas. El programa ofrece soluciones integrales de gestión de vacunas sin requerir inversiones iniciales significativas en equipos.

El paquete de arrendamiento incluye refrigeradores, congeladores, unidades de ultra frío, generadores, equipos informáticos y kits de clínicas móviles, todos monitoreados por su sistema propietario Sentry. Esta solución ayuda a las organizaciones a evitar invertir aproximadamente $100,000 en la compra de equipos.

El historial de la empresa incluye la gestión de 2.27 millones de dosis de vacuna COVID-19, 32.2 millones de suministros de pruebas y 113,401 terapias COVID-19 para el Departamento de Servicios de Salud del Estado de Texas desde abril de 2020 hasta enero de 2024. Callan JMB opera centros de gestión de vacunas en Texas, Oregón e Illinois.

Callan JMB (NASDAQ: CJMB)는 정부 기관 및 민간 조직을 대상으로 면역 관리 인프라를 위한 혁신적인 임대 프로그램을 시작했습니다. 이 프로그램은 상당한 초기 장비 투자가 필요 없는 포괄적인 백신 관리 솔루션을 제공합니다.

임대 패키지에는 냉장고, 냉동고, 초저온 장치, 발전기, 컴퓨터 장비 및 이동 클리닉 키트가 포함되어 있으며, 모두 그들의 독점 시스템인 Sentry에 의해 모니터링됩니다. 이 솔루션은 조직이 장비 구매에 약 $100,000를 투자하지 않도록 도와줍니다.

회사의 실적에는 2020년 4월부터 2024년 1월까지 텍사스 주 보건 서비스부를 위해 227만 COVID-19 백신 접종량, 3220만 테스트 용품, 113,401 COVID-19 치료제를 관리한 기록이 포함됩니다. Callan JMB는 텍사스, 오리건, 일리노이에서 백신 관리 센터를 운영하고 있습니다.

Callan JMB (NASDAQ: CJMB) a lancé un programme de location innovant pour l'infrastructure de gestion des vaccinations, ciblant les agences gouvernementales et les organisations privées. Le programme propose des solutions complètes de gestion des vaccins sans nécessiter d'importants investissements initiaux en équipements.

Le forfait de location comprend des réfrigérateurs, des congélateurs, des unités ultra-froides, des générateurs, des équipements informatiques et des kits de clinique mobile, tous surveillés par leur système propriétaire Sentry. Cette solution aide les organisations à éviter d'investir environ $100,000 dans l'achat d'équipements.

Le parcours de l'entreprise comprend la gestion de 2,27 millions de doses de vaccin COVID-19, 32,2 millions de fournitures de test et 113,401 thérapies COVID-19 pour le Département des Services de Santé de l'État du Texas d'avril 2020 à janvier 2024. Callan JMB gère des centres de gestion des vaccins au Texas, en Oregon et en Illinois.

Callan JMB (NASDAQ: CJMB) hat ein innovatives Leasingprogramm für die Infrastruktur des Impfmanagements gestartet, das sich an Regierungsbehörden und private Organisationen richtet. Das Programm bietet umfassende Lösungen für das Impfstoffmanagement, ohne dass erhebliche Vorabinvestitionen in Ausrüstung erforderlich sind.

Das Leasingpaket umfasst Kühlschränke, Gefrierschränke, ultrakalte Einheiten, Generatoren, Computergeräte und mobile Klinik-Kits, die alle von ihrem proprietären Sentry-System überwacht werden. Diese Lösung hilft Organisationen, etwa $100,000 in den Kauf von Geräten zu vermeiden.

Die Erfolgsbilanz des Unternehmens umfasst die Verwaltung von 2,27 Millionen COVID-19-Impfstoffdosen, 32,2 Millionen Testmaterialien und 113.401 COVID-19-Therapien für das Texas Department of State Health Services von April 2020 bis Januar 2024. Callan JMB betreibt Impfstoffmanagementzentren in Texas, Oregon und Illinois.

Positive
  • New revenue stream from comprehensive lease program
  • Proven track record managing 2.27M vaccine doses
  • Established infrastructure across three states
  • Proprietary monitoring technology (Sentry system)
Negative
  • High capital investment required for equipment fleet
  • Dependent on government contracts and funding
  • Competition from equipment manufacturers offering direct sales

Insights

Callan JMB's new immunization infrastructure lease program represents a strategic pivot toward a recurring revenue model that could significantly enhance the company's financial profile. By converting what would typically be a $100,000+ capital expenditure for customers into an operational expense model, CJMB is addressing a critical market gap while potentially creating a more predictable revenue stream for itself.

This lease program effectively expands CJMB's total addressable market by lowering the financial barrier to entry for government agencies and private organizations needing vaccine management infrastructure. The company is leveraging its established logistics expertise and proprietary monitoring technology to create a bundled offering that generates value beyond what customers could achieve independently.

What makes this particularly noteworthy is CJMB's demonstrated capability in this space, having successfully managed 2.27 million COVID-19 vaccine doses and 32.2 million testing supplies for Texas. This track record provides credibility for the new offering and suggests the company has the operational infrastructure to execute effectively.

For a company with a market cap of just $20.2 million, this product launch could represent a material growth opportunity if successfully implemented and scaled. The program aligns well with public health funding realities, specifically targeting scenarios where grants don't cover equipment purchases - a thoughtful positioning that addresses a genuine market need.

SPRING BRANCH, Texas, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services, today announced a new comprehensive lease program for vaccine management that will enable government agencies and private organizations to provide crucial immunizations without the economic burden of purchasing the necessary equipment outright.

Under this program, Callan JMB can not only assist agencies in developing their plans, but can lease refrigerators, freezers, ultra-cold units, and generators to them, all monitored by Callan JMB’s proprietary Sentry monitoring system. The lease program includes computer equipment, compliant inventory management, and mobile clinic kits that keep vaccines at required temperatures throughout transit and include everything needed for successful immunizations. While there are grants available for vaccine management plans through Public Health Emergency Preparedness (PHEP) programs, many do not cover the purchase of equipment.

“Our lease program eliminates the need for public health organizations to invest upwards of $100,000 in equipment for vaccine storage and distribution,” commented Wayne Williams, CEO of Callan JMB. “We can locate warehouse space, set up and monitor the equipment, and even provide personnel. For agencies that are dealing with as many as 3 million doses of vaccines, having a reliable and compliant facility with this added layer of flexibility and cost savings is an absolute necessity.”

Drawing on extensive emergency preparedness and response logistics expertise, Callan JMB's vaccine and compliance specialists offer this lease program across all public health initiatives—from immunization programs and rural medical response units to pandemic preparedness plans. The program delivers a state-of-the-art, full-service management system emphasizing quality, responsibility, and accountability.

Since 2009, Callan JMB has pioneered the development of fully compliant vaccine management centers for secure storage and efficient distribution. The COVID-19 pandemic proved to be the ultimate test for these facilities, with the Company's centers in Texas, Oregon, and Illinois demonstrating exceptional effectiveness. From April 2020 through January 2024, Callan JMB successfully managed the distribution of 2.27 million COVID-19 vaccine doses, 32.2 million testing supplies, and 113,401 COVID-19 therapeutics for the Texas Department of State Health Services.

About Callan JMB
Callan JMB is an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services to secure medical materials and protect patients and communities with compliant, safe, and effective medicines. Our combined expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance and emergency preparedness is unparalleled in the industry. We offer the Gold Standard in client experience with customizable interfaces, next-level reliability in shipping and environmental sustainability in our specialty packaging. For more information please visit www.callanjmb.com.

Forward-Looking Statement
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs, such as “will,” “should,” “would,” “may,” and “could,” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance, or achievements to be materially different from any anticipated results, performance, or achievements for many reasons. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see the Company's Registration Statement Under the Securities Act of 1933 on Form S-1, including but not limited to the discussion under “Risk Factors” therein, which the Company filed with the SEC and which may be viewed at http://www.sec.gov/.

Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
CallanJMB@kcsa.com
212.896.1254


FAQ

What does CJMB's new lease program include for vaccine management?

The program includes refrigerators, freezers, ultra-cold units, generators, computer equipment, mobile clinic kits, and Sentry monitoring system, along with warehouse space and personnel support.

How much can organizations save through CJMB's vaccine infrastructure lease program?

Organizations can avoid upfront investments of over $100,000 in vaccine storage and distribution equipment through the lease program.

How many COVID-19 vaccine doses has CJMB managed for Texas health services?

From April 2020 to January 2024, CJMB managed 2.27 million COVID-19 vaccine doses for Texas Department of State Health Services.

Where does CJMB operate its vaccine management centers?

CJMB operates vaccine management centers in Texas, Oregon, and Illinois.

Callan JMB Inc.

NASDAQ:CJMB

CJMB Rankings

CJMB Latest News

CJMB Stock Data

19.29M
1.28M